NASDAQ:VERA | Cash Flow Statement | Vera Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$109.47M
2026-03-31-$121.03M$140,000.00-$106.5M$23,000.00-$137.82M$3.94M
2025-12-31-$91.1M$135,000.00-$69.99M$102,000.00$80.66M$0.00$286.28M
2025-09-30-$80.29M
2025-06-30-$76.53M
2025-03-31-$51.69M$85,000.00-$54.41M$187,000.00$15.32M$1.53M
2024-12-31-$43.43M$55,000.00-$39.18M$645,000.00-$221.38M$0.00$325.96M
2024-09-30-$46.63M
2024-06-30-$33.71M
2024-03-31-$28.38M$11,000.00-$33.83M$0.00-$219.29M$276.54M
2023-12-31-$25.66M$4,000.00-$25.14M$63,000.00$18.56M$0.00$24.83M
2023-09-30-$20.1M
2023-06-30-$20.16M
2023-03-31-$30.07M-$26.29M$0.00$12.23M$107.98M
2022-12-31-$32.44M-$21.16M$0.00$13.44M$20.71M
2022-09-30-$24.68M
2022-06-30-$14.85M
2022-03-31-$17.09M-$8.98M$18,000.00-$39.46M$80.27M
2021-12-31-$16.85M-$6.44M$0.00-$5M$4.92M
2021-09-30-$7.61M
2021-06-30-$3.44M
2021-03-31-$4.71M-$4.12M$0.00$0.00-$28,000.00
2020-12-31-$42.88M-$27.38M$0.00$57,000.00$79.8M
2020-09-30-$4.46M
2020-06-30-$3.6M
2020-03-31-$2.47M-$2.31M$52,000.00-$52,000.00$4.97M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$299.62M$468,000.00-$241.1M$630,000.00$194.29M$0.00$308.9M
2024-12-31-$152.15M$105,000.00-$134.68M$972,000.00-$425.03M$13,000.00$606.67M
2023-12-31-$95.99M$21,000.00-$92.18M$63,000.00-$39.43M$0.00$133.54M
2022-12-31-$89.06M-$67.6M$62,000.00-$70.55M$101.93M
2021-12-31-$32.61M-$23.71M$0.00-$4.2M$53.88M
2020-12-31-$53.41M-$34.81M$99,000.00-$42,000.00$85.29M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.